JUPITER MEDICAL CENTER AND ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ANNOUNCE PARTNERSHIP FOR CLINICAL RESEARCH

January 19, 2017

Trial for Treatment of Crohn’s Disease is First of Many Research Studies
Coming to South Florida

 

JUPITER, FLA. (January 19, 2017) –  Jupiter Medical Center has signed a formal agreement with the Icahn School of Medicine at Mount Sinai to collaborate on research projects and clinical trials with the goal of fostering discoveries to advance the diagnosis, treatment, and prevention of disease. These joint efforts in science and medicine will make a wide range of clinical trials available to patients at Jupiter Medical Center and lead to instrumental advances in biomedical research.

“Progressive partnerships like this are an important part of how we consistently deliver world-class health care to the region,” said John Couris, President and CEO of Jupiter Medical Center. “This collaboration is a milestone that will increase the availability of drugs and novel therapies for patients in our local community.“

“Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies,” said Raymond Golish, MD, medical director of Clinical Research at Jupiter Medical Center. “We are excited to conduct clinical research with our partners at the Icahn School of Medicine at Mount Sinai, an institution which is world-renowned for groundbreaking medical and scientific inquiry, discovery, and development.“

"We are proud of our strong clinical relationship with Jupiter Medical Center,” said Arthur Klein, MD, President of the Mount Sinai Health Network.  “This research collaboration will benefit patients impacted by GI diseases in the Palm Beach County community."

The first study to come out of this partnership, now underway, seeks to discover and deliver more effective treatment for Crohn’s disease, a chronic inflammatory bowel condition that can lead to abdominal pain, diarrhea, weight loss and, in some cases, even life-threatening complications. More than half a million Americans have been diagnosed with the disease. This study will be under the supervision and direction of Chester J. Maxson, MD, medical director of the Jupiter Medical Center/Mount Sinai New York Frenchman’s Creek Digestive Health Center.

For more information about Jupiter Medical Center/Mount Sinai research trials, please contact the Jupiter Medical Center clinical research department at 561-263-5791.

About Jupiter Medical Center

A not-for-profit 327-bed regional medical center consisting of 207 private acute-care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center is reimagining how to restore the community’s health and wellness. Award-winning physicians, world-class partnerships and innovative techniques and technology enable Jupiter Medical Center to provide a broad range of services with specialty concentrations in cardiology, oncology, imaging, orthopedics & spine, digestive health, emergency services, lung & thoracic, women’s health, weight management and men’s health.

 

Founded in 1979, Jupiter Medical Center has approximately 1,500 team members, 575 physicians and 640 volunteers. Jupiter Medical Center continues to perform in the top 10% of hospitals for patient quality and satisfaction. For more information on Jupiter Medical Center, please call (561) 263-2234 or visit Jupitermed.com.

About the Icahn School of Medicine

The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, an integrated health care system which includes seven hospitals and an expanding ambulatory network serving approximately 4 million patients per year.

The School has more than 1,800 students in MD, PhD, and Master’s programs and post-doctoral fellowships; more than 5,600 faculty members; over 2,000 residents and fellows; and 23 clinical and research institutes and 34 academic departments. It is ranked among the highest in the nation in National Institutes of Health funding per principal investigator. The School was the first medical school in the country to create a progressive admissions approach for students who seek early assurance of admission through the FlexMed program.

 

The Graduate School of Biomedical Science trains PhD and MD/PhD students, and offers master’s-level programs in areas such as genetic counseling, clinical research, biomedical sciences, and public health, and an online master’s degree in health care delivery leadership. The seamless connections between our medical school, graduate school, and hospital campuses provide an extraordinary environment for translating scientific discoveries into clinical treatments.

 

For more information, visit http://icahn.mssm.edu or find the Icahn School of Medicine at Mount Sinai on Facebook, Twitter, YouTube, and LinkedIn.

Press ReleasesPR 2016